Inositol Polyphosphate Kinases, Fungal Virulence and Drug Discovery.
Ontology highlight
ABSTRACT: Opportunistic fungi are a major cause of morbidity and mortality world-wide, particularly in immunocompromised individuals. Developing new treatments to combat invasive fungal disease is challenging given that fungal and mammalian host cells are eukaryotic, with similar organization and physiology. Even therapies targeting unique fungal cell features have limitations and drug resistance is emerging. New approaches to the development of antifungal drugs are therefore needed urgently. Cryptococcus neoformans, the commonest cause of fungal meningitis worldwide, is an accepted model for studying fungal pathogenicity and driving drug discovery. We recently characterized a phospholipase C (Plc1)-dependent pathway in C. neoformans comprising of sequentially-acting inositol polyphosphate kinases (
SUBMITTER: Li C
PROVIDER: S-EPMC5753137 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA